Findings from a meta‐analysis suggested that chronic PDE5 inhibitor use imparts a beneficial cardiac inotropic effect together with anti‐remodeling properties across different populations, suggesting that patients with longstanding cardiac disease could benefit from PDE5 inhibition‐induced cardio‐protection [4]. This evidence concerns the gene PDE5A and heart disorder.